Closed annaschultze closed 4 years ago
Covariate | Issue | Signed off? |
---|---|---|
ICS (Single Constituent) | ebmdatalab/opencorona-ics-research#25 | No |
Oral Steroids (Single Constituent) | ebmdatalab/opensafely-codelist-development#17 | No |
SABA (Single Constituent) | ebmdatalab/opensafely-codelist-development#15 | Yes |
LABA (Single Constituent) | ebmdatalab/opencorona-ics-research#15 | No |
LAMA (Single Constituent) | ebmdatalab/opencorona-ics-research#14 | No |
LABA + ICS | ebmdatalab/opencorona-ics-research#16 | No |
LABA + LAMA | ebmdatalab/opencorona-ics-research#20 | No |
LABA + LAMA + ICS | ebmdatalab/opencorona-ics-research#18 | No |
LTRA (Single Constituent) | ebmdatalab/opencorona-ics-research#17 | No |
Nebules | ebmdatalab/opencorona-ics-research#27 | No |
Oxygen Therapy | ebmdatalab/opencorona-ics-research#19 | No |
COPD | ebmdatalab/opencorona-ics-research#12 | No |
Other respiratory conditions | ebmdatalab/opencorona-ics-research#10 | No |
Age | ebmdatalab/opensafely-risk-factors-research#49 | Yes |
Sex | ebmdatalab/opensafely-risk-factors-research#46 | Yes |
Smoking status | ebmdatalab/opensafely-codelist-development#1 | Yes |
BMI | ebmdatalab/opensafely-risk-factors-research#51 | Yes |
Ethnicity | ebmdatalab/opensafely-codelist-development#7 | No |
Hypertension | ebmdatalab/opensafely-codelist-development#16 | No |
Ischaemic Heart Disease | ebmdatalab/tpp-sql-notebook#83 | No |
Heart Failure | ebmdatalab/tpp-sql-notebook#80 | No |
Diabetes Mellitus | ebmdatalab/opensafely-codelist-development#8 | Yes |
Cancer | ebmdatalab/opensafely-codelist-development#10 | Yes |
Chronic Respiratory Disease | ebmdatalab/opensafely-codelist-development#6 | Yes |
Asthma | ebmdatalab/opensafely-codelist-development#15 | Yes |
Splenectomy or Sickle Cell | ebmdatalab/opensafely-codelist-development#4 | Yes |
Conditions affecting Immunity | ebmdatalab/opensafely-codelist-development#11 | Yes |
Immunosuppressants | ebmdatalab/opensafely-codelist-development#18 | No |
Organ Transplant Status | ebmdatalab/opensafely-codelist-development#9 | Yes |
Chronic Kidney Disease | ebmdatalab/opensafely-risk-factors-research#50 | Yes |
Primary care consultation rate | ebmdatalab/opencorona-ics-research#24 | No |
Prior hospitalisation | ebmdatalab/tpp-sql-notebook#20 | No |
Prior exacerbation | ebmdatalab/opencorona-ics-research#11 | No |
Vaccination status | ebmdatalab/opencorona-ics-research#23 | No |
@brianmackenna we'll need quite a few different drugs, Ian mentioned single LABA, single LAMA, LABA+LAMA+ICS, LTRA, muscarinic antagonists and oral steroids. Plus oxygen therapy (by clinical code rather than drug code). What do you think the best way of organising this is, a single issue and sign off for all or separate?
I think we should do separate issues to some extent in order to record and document all decisions however I will try to keep all notebooks in the same repos. Sound good?
For example I can rename this asthma meds repo and add other lists in, steroid repo is here etc etc
@brianmackenna have gone over the list of medications required with Ian, and think the above should now be accurate. I created separate issues for them - apart from nebules as wasn't sure whether this existed separately already.